510(k) Report

510(k) · Cleared

Cleared

Optimum GP (Roflufocon a,B,C,D&E) Daily Wear Contact Lens.

K070628510(k) TraditionalCleared May 1, 200755-day reviewClass II21 CFR 886.5916

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Contamac, Ltd. · HQD Lens, Contact (Other Material) - Daily

Cleared on May 1, 2007 as substantially equivalent to K053124 (Bausch & Lomb, Incorporated, 2006) and 1 other predicate after a 55-day review. Its family tree reaches back 4 generations to 1994. 10 later devices descend from it.

Decided
May 1, 2007
Review
55 days
Class
Class II
Product code
HQD
Recalls
None
Predicates
2

Its longest line of descent runs back 4 generations to K943177 (1994). 5 ancestors in all. 10 later devices descend from it, 2 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2002: 1 other ancestor2016: 2 descendants cleared2021: 2 descendants cleared2018: 1 descendant cleared2017: 1 descendant cleared2024: 4 descendants clearedK943177 · Boston (R) 7 - 30(Enflufocon a) · Polymer Technology Corp. · 1994 · recalledK000795 · Rigid Gas Permeable Contact Lens · Polymer Technology · 2000K020006 · Dyna Intra-Limbal Lens · Lens Dynamics, Inc. · 2002K053124 · Boston ES (Enflufocon a), Boston EO (Enflufocon B) and Boston XO (Hexafocon a) Rigid Gas Permeable Contact Lenses · Bausch & Lomb, Incorporated · 20061990200020102020
Other ancestors, by generationDescendants, by generation 2 generations back: 1 other ancestor 1 generation forward: 2 descendants2 generations forward: 4 descendants3 generations forward: 1 descendant4 generations forward: 3 descendants K053124 · Boston ES (Enflufocon a), Boston EO (Enflufocon B) and Boston XO (Hexafocon a) Rigid Gas Permeable Contact Lenses · Bausch & Lomb, Incorporated · 2006K020006 · Dyna Intra-Limbal Lens · Lens Dynamics, Inc. · 2002K000795 · Rigid Gas Permeable Contact Lens · Polymer Technology · 2000K943177 · Boston (R) 7 - 30(Enflufocon a) · Polymer Technology Corp. · 1994 · recalled0
  1. Root · 4 generations backK943177 Boston (R) 7 - 30(Enflufocon a)Polymer Technology Corp. · 1994 · Recalled
  2. 3 generations backK000795 Rigid Gas Permeable Contact LensPolymer Technology · 2000
  3. 2 generations backK020006 Dyna Intra-Limbal LensLens Dynamics, Inc. · 2002
  4. 1 generation backK053124 Boston ES (Enflufocon a), Boston EO (Enflufocon B) and Boston XO…Bausch & Lomb, Incorporated · 2006
  5. This deviceK070628 Optimum GP (Roflufocon a,B,C,D&E) Daily Wear Contact Lens.Contamac, Ltd. · 2007
  6. Descendant · cites it directly · 8 of its ownK161100 Optimum GP with HPT (roflufocon A, B, C, D, and E) Daily Wear…Contamac, Ltd. · 2016
  7. Descendant · 2 generations on · 4 of its ownK213538 Acuity 200 with Tangible Hydra-PEG (fluoroxyfocon A) Rigid Gas…Acuity Polymers, Inc. · 2021
  8. Descendant · 3 generations on · 3 of its ownK240618 Acuity 200™ (fluoroxyfocon A) Rigid Gas Permeable Contact Lens…Acuity Polymers, Inc. · 2024
  9. Descendant · 2 generations on · 1 of its ownK171575 ENFLU 18 (enflufocon A) Daily Wear Contact LensContamac, Ltd. · 2017
  10. Descendant · 4 generations on · 0 of its ownK242393 Acuity 181™ (tisilfocon A) and Acuity 181™ (tisilfocon A) with…Acuity Polymers, Inc. · 2024

Showing 5 of 10 descendants. See all descendants

Descendants cleared per year

2016: 22017: 12018: 12021: 22024: 4
2016high 4 (2024) · low 0 (2019)2026

Most influential descendants

Showing 5 of 10 · See all
  • K161100Optimum GP with HPT (roflufocon A, B, C, D, and E) Daily Wear Contact LensesContamac, Ltd. · 2016 · cites it directly8descendants
  • K213538Acuity 200 with Tangible Hydra-PEG (fluoroxyfocon A) Rigid Gas Permeable Contact LensAcuity Polymers, Inc. · 2021 · 2 generations on4descendants
  • K240618Acuity 200™ (fluoroxyfocon A) Rigid Gas Permeable Contact Lens; Acuity 100™ (hexafocon…Acuity Polymers, Inc. · 2024 · 3 generations on3descendants
  • K171575ENFLU 18 (enflufocon A) Daily Wear Contact LensContamac, Ltd. · 2017 · 2 generations on1descendant
  • K242393Acuity 181™ (tisilfocon A) and Acuity 181™ (tisilfocon A) with Tangible™ Hydra-PEG®…Acuity Polymers, Inc. · 2024 · 4 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K943177Boston (R) 7 - 30(Enflufocon a)Polymer Technology Corp.19941
−3K000795Rigid Gas Permeable Contact LensPolymer Technology2000—
−2K020006Dyna Intra-Limbal LensLens Dynamics, Inc.2002—
−1K053124Boston ES (Enflufocon a), Boston EO (Enflufocon B) and Boston XO (Hexafocon a)…Bausch & Lomb, Incorporated2006—
0 (this device)K070628Optimum GP (Roflufocon a,B,C,D&E) Daily Wear Contact Lens.Contamac, Ltd.2007—
+1K161100Optimum GP with HPT (roflufocon A, B, C, D, and E) Daily Wear Contact LensesContamac, Ltd.2016—
+2K213538Acuity 200 with Tangible Hydra-PEG (fluoroxyfocon A) Rigid Gas Permeable…Acuity Polymers, Inc.2021—
+3K240618Acuity 200™ (fluoroxyfocon A) Rigid Gas Permeable Contact Lens; Acuity 100™…Acuity Polymers, Inc.2024—
+2K171575ENFLU 18 (enflufocon A) Daily Wear Contact LensContamac, Ltd.2017—
+4K242393Acuity 181™ (tisilfocon A) and Acuity 181™ (tisilfocon A) with Tangible™…Acuity Polymers, Inc.2024—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200210

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201620
201710
201810
202120
202440
FIG. 1 — Lineage of K070628, 1994–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in HQD? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new HQD device

  1. #1 K240618 Acuity 200™ (fluoroxyfocon A) Rigid Gas…score 19.4 · 12 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K053124Boston ES (Enflufocon a), Boston EO (Enflufocon B) and Boston XO (Hexafocon a) Rigid Gas…
Summary page 2
…and the Boston XO® (hexafocon A) Rigid Gas 1400 North Goodman Street Permeable Contact Lenses 510(k) #K053124 Rochester, NY 14603 2.) Lens Dynamics Dyna Intra-Limbal Lens 5 10(k) #K020006 14998…
Bausch & Lomb, Incorporated2006—
*K020006Dyna Intra-Limbal Lens
Summary page 2
…Street Permeable Contact Lenses 510(k) #K053124 Rochester, NY 14603 2.) Lens Dynamics Dyna Intra-Limbal Lens 5 10(k) #K020006 14998 W. 6 th Avenue, Suite 830 Golden, CO 80401 Device Description: The OPTIMUM GP (roflufocon A, B, C, D & E)…
Lens Dynamics, Inc.2002—

Also cleared against K053124: 7 other devices →

What descends from it? (10)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K161100Optimum GP with HPT (roflufocon A, B, C, D, and E) Daily Wear Contact LensesContamac, Ltd.20168
K152724Eyeprintpro (Roflufocon D) Scleral GP LensesAdvanced Vision Technologies20160

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 13 years and passes through 5 companies; a new generation was cleared every 3.8 years on median.
  • 1 of the 5 ancestors has a recall of any class.
  • Of its descendants, K161100 (Contamac, Ltd., 2016) has gone furthest, with 8 descendants of its own.
  • 7 other devices also cite its predicate K053124.

How does its category compare?

All HQD devices

HQD Lens, Contact (Other Material) - Daily: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.

FDA decisions per year · HQD

5in 2024

2007: 42008: 52009: 22011: 22012: 22014: 12016: 72017: 92018: 52019: 22020: 12021: 32022: 32023: 32024: 52026 (partial year): 1
2007high 9 (2017) · low 0 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · HQD

80in 2024

2007: 78 days median2008: 100 days median2016: 119 days median2017: 66 days median2018: 53 days median2021: 123 days median2022: 29 days median2023: 77 days median2024: 80 days median
2007high 123 (2021) · low 29 (2022)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · HQD

1in 2010

2010: 1
2007high 1 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · HQD

2in 2025

2007: 62008: 82009: 122010: 22011: 72012: 102013: 152014: 262015: 52016: 12017: 32019: 52020: 22021: 32022: 32023: 82024: 32025: 2
2007high 26 (2014) · low 0 (2018)2025

MAUDE reports naming product code HQD, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200747806
2008510008
20092—012
20100—12
20112—07
20122—010
20130—015
20141—026
20150—05
2016711901
201796603
201855300
20192—05
20201—02
2021312303
202232903
202337708
202458003
20250—02
20261—0—

What is it indicated for?

The OPTIMUM GP (roflufocon A, B, C, D & E) Daily Wear Contact Lens may be prescribed in otherwise non-diseased eyes that require a rigid gas permeable lens for the management of irregular corneal conditions such as; keratoconus, pellucid marginal degeneration or following penetrating keratoplasty or refractive (e.g. LASIK) surgery.

Eyecare practitioners may prescribe the lenses for frequent/planned replacement wear, with cleaning, disinfection and scheduled replacement. When prescribed for frequent/planned replacement wear, the lens may be cleaned and disinfected using a chemical (not heat) lens care system.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K070628: Optimum GP (Roflufocon a,B,C,D&E) Daily Wear Contact Lens..” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K070628

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026